Teva reports positive skin treatment drug results
The Israeli company reported in the study that patients showed improvements in skin pigmentation with vitiligo
Assessment
Teva's positive vitiligo drug results could open a new therapeutic pathway for a condition with limited treatment options. The improvements in skin pigmentation observed in the study are a meaningful clinical signal, but the durability and safety profile will determine regulatory and commercial potential. Investors will watch for the full data presentation and the company's next steps toward a pivotal trial.